查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1663432

造影剂市场，按产品、按方式、按给药途径、按应用、按最终用途、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Contrast Media Market, By Product, By Modality, By Route of Administration, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年造影剂市场规模价值为 65.142 亿美元，2025 年至 2032 年期间的复合年增长率为 8.00%。

造影剂市场-市场动态

医疗支出增加

市场扩张的主要驱动力是医疗保健支出的成长。预计近年来许多国家的医疗支出大幅上涨将对市场产生影响。例如，在预测期内，由于可支配收入的增加，医疗设施支出的预期成长将推动各种诊断影像对造影剂的需求。例如，医疗保健支出占 2022 年美国 GDP 的 18.3%，高于 2019 年的 17.6%。因此，医疗费用的上涨将极大地影响先进医疗设施的采用。因此，造影剂市场的扩张预计将受到各国增加医疗保健支出的推动，以改善医疗保健基础设施，满足患者日益增长的需求，并提供尖端的医疗服务。

造影剂市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 8.00%

根据产品细分，预计碘化物将在 2024 年占据最大市场份额

根据给药途径细分，静脉注射是 2024 年的主要细分市场

根据应用细分，神经系统疾病是 2024 年的主要细分领域

根据最终用途细分，医院将成为 2024 年的主要细分市场

从地区来看，北美是 2024 年最大的收入来源

造影剂市场-細項分析：

全球造影剂市场根据产品、方式、给药途径、应用、最终用途和地区进行细分。

根据产品，市场分为微泡、碘化、钆基和钡基。 2024 年，碘化物将占据市场主导地位，这归因于 CT 和 X 射线技术的广泛使用以及稳定的非离子碘化物质可用于更好的诊断。虽然钡基造影剂有时用于口服和直肠给药，但碘造影剂通常透过静脉注射。使用以碘为基础的造影剂可以改善 CT 和 X 光影像。此外，它们还用于改善大脑、软组织、动脉和静脉、内臟和胃肠道的成像。除了癌症之外，碘造影剂还可用于多种疾病，例如神经系统、胃肠道、肾臟病、心血管和肌肉骨骼问题。

根据应用，市场分为肌肉骨骼疾病、癌症、肾臟疾病、心血管疾病、胃肠道疾病、神经系统疾病和其他疾病。 2024 年，神经系统疾病类别占据主导地位。由于 MRI 造影剂比 CT 能产生更优质的脑结构影像，因此鼓励使用它们来对神经系统疾病的中枢神经系统进行诊断评估。钆基造影剂用于显影脱髓鞘、发炎和肿瘤病变。在三分之一的 MRI 中，使用钆基造影剂来改善影像品质。透过使血管、发炎和肿瘤更加明显，这些造影剂提高了诊断的准确性。美国用于诊断神经系统疾病的三种最常用的大环钆造影剂是Gadavist、Dotarem和Prohance。成人和两岁及以上的儿童可以透过静脉注射来观察异常血管化的大脑、脊椎和相关组织异常。

造影剂市场-地理洞察

2024 年，北美在全球造影剂市场占据主导地位。政府和非政府组织对生物医学研究的资助增加是该市场崛起的主要原因。例如，2022 年 10 月 3 日，SNMMI 宣布拨款 10 万美元用于治疗小叶乳房肿瘤的核子医学影像研究和开发。预计这将导致大幅扩张。该领域资金的增加使得许多研究计画得以开展，这将为需要造影剂的新产品的发布带来更多创意。此外，投资医疗设备的新创企业数量不断增加是推动该地区市场收入成长的另一个驱动力。

然而，在整个预测期内，预计亚太地区的复合年增长率最快。这是因为医疗保健基础设施越来越好，人们也越来越意识到早期诊断的重要性。此外，推动该地区市场收入成长的另一个原因是癌症、神经系统疾病、肠道疾病和心血管疾病（CVD）等慢性疾病的发生率不断上升。例如，根据世界卫生组织 (WHO) 的数据，在印度，非传染性疾病占所有死亡人数的 63%，其中心血管疾病占死亡人数的 27%。此外，预计新创企业数量的增加将显着影响创新分子影像技术的数量。在整个预测期内，预计他们还有望加速市场扩张。

造影剂市场-竞争格局：

主要公司有拜耳公司、通用电气公司、Jodas Expoim Pvt。 Ltd.、Lantheus 和 Guerbet 等公司正在采用合併、收购和合作等策略来扩大其市场份额。此外，他们也正在推出新产品。为了增加客户群和国际市场份额，各大公司都在进行併购。收购为公司提供了更好的投资组合和更广泛的地理覆盖范围，有助于它们扩大影响力。疾病指征延伸在该行业很普遍，因为它使公司能够获得特定人口群体的信任。透过获得某些适应症的批准，企业可以提高其产品的采用率并针对特定的患者群体。例如，2023 年 4 月，GE HealthCare 推出了用于磁振造影 (MRI) 的大环非离子钆基造影剂 (GBCA) Pixxoscan (gadobutrol)，扩大了其造影剂的范围。 Pixxoscan 透过分散程序 (DCP) 进行监管评估后，在奥地利获得了行销许可。

近期发展

2024 年 8 月：拜耳公司表示，一种具有更好的弛豫性和安全性的新型钆基造影剂的 III 期临床试验已经完成。这种药剂可为神经学应用提供改进的 MRI 成像能力。

2024 年 4 月：GE Healthcare 推出了一种新型 AI 造影剂注射装置，旨在透过优化造影剂剂量和时间来定製成像方案，从而提高影像品质并降低造影剂肾病变的风险。

2024 年 3 月：美国食品药物管理局批准了 Lantheus Holdings Inc. 的 DEFINITY（Perflutren 脂质微球）补充新药申请 (sNDA)，DEFINITY 是一种超音波增强剂，旨在用于心臟超音波检查不佳的儿科患者。

2023 年 6 月：美国食品药物管理局批准了碘基造影剂 Iopromide-300 和 -370（Ultravist）。除了乳房 X 光照相和/或超音波之外，该产品还可用于观察成人已知或疑似乳房病变。

目录

第 1 章：造影剂市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 对比剂市场产品片段
    • 对比剂市场片段（按方式）
    • 造影剂市场依给药途径分类
    • 造影剂市场片段（按应用）
    • 造影剂市场片段（依最终用途）
    • 造影剂市场（按国家/地区）
    • 对比剂市场（按地区）
  • 竞争洞察

第 3 章：造影剂主要市场趋势

  • 造影剂市场驱动因素
    • 市场驱动因素的影响分析
  • 显影剂市场限制
    • 市场限制的影响分析
  • 造影剂市场机会
  • 造影剂市场未来趋势

第 4 章：造影剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：造影剂市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠肺炎疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长领域
    • 最鬆散的部分
    • 边际损失部分

第 6 章：造影剂市场格局

  • 2024 年造影剂市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：造影剂市场 - 依产品分类

  • 概述
    • 按产品细分的份额分析
    • 微泡
    • 碘化
    • 钆基
    • 钡基

第 8 章：造影剂市场 - 依方式

  • 概述
    • 依方式进行细分份额分析
    • 超音波
    • X光/电脑断层扫描
    • 磁振造影

第 9 章：造影剂市场 - 依给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服途径
    • 静脉
    • 直肠给药

第 10 章：造影剂市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肌肉骨骼疾病
    • 癌症
    • 肾臟疾病
    • 心血管疾病
    • 胃肠道疾病
    • 神经系统疾病
    • 其他的

第 11 章：造影剂市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 诊断影像中心
    • 其他的

第 12 章：造影剂市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美造影剂主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品划分）
    • 北美市场规模及预测（依方式）
    • 北美市场规模及预测（按给药途径）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（依最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲造影剂主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品划分）
    • 欧洲市场规模及预测（依方式）
    • 欧洲市场规模及预测（依管理途径）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（依最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区造影剂主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太市场规模及预测（依产品划分）
    • 亚太市场规模及预测（依方式）
    • 亚太市场规模及预测（依管理途径）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（依最终用途划分）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲造影剂主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品划分）
    • 拉丁美洲市场规模及预测（按方式）
    • 拉丁美洲市场规模及预测（按管理途径）
    • 拉丁美洲市场规模与预测，按应用划分
    • 拉丁美洲市场规模及预测（依最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲造影剂主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品划分）
    • 中东和非洲市场规模及预测（按方式）
    • 中东和非洲市场规模及预测（按管理路线划分）
    • 中东和非洲市场规模及预测（按应用划分）
    • 中东和非洲市场规模及预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 13 章：主要供应商分析-造影剂产业

  • 竞争仪錶板
  • 公司简介
    • Bayer AG
    • General Electric Company
    • Jodas Expoim Pvt. Ltd.
    • Lantheus
    • Guerbet
    • SANOCHEMIA Pharmazeutika GmbH
    • TAEJOON PHARM Co. Ltd.
    • Beijing Beilu Pharmaceuticals Company Limited
    • Bracco SpA
    • iMAX Diagnostic Imaging Limited
    • JB Chemicals & Pharmaceuticals Limited
    • Nano Therapeutics Pvt Ltd
    • Trivitron Healthcare
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4669

REPORT HIGHLIGHT

Contrast Media Market size was valued at US$ 6,514.2 Million in 2024, expanding at a CAGR of 8.00% from 2025 to 2032.

A contrast medium is a material that is used in medical imaging to improve the contrast of bodily fluid structures. Contrast media improve the visibility of the targeted blood vessels, tissues, or structures. In addition to emitting radiation, contrast media also change or absorb incoming electromagnetic or ultrasonic waves. MRIs and ultrasounds typically use one of the following contrast agents: barium-based, iodinated, gadolinium-based, or microbubble. Growing alliances and acquisitions among companies to launch new products, rising rates of cancer, neurological and cardiovascular illnesses, and new developments in contrast media are some of the reasons that are expected to propel the worldwide contrast media market throughout the forecast period. Moreover, some of the main factors propelling the growth of the contrast media market throughout the forecast period include rising incidence and prevalence of cancer and heart illnesses, growing demand for image-guided diagnostics and procedures, and technical improvements in medical imaging techniques. However, the high cost of the contrast media injectors and the negative consequences of using contrast media, such as bluish skin, vomiting, and stomach pains, are some of the factors holding back the growth of the worldwide contrast media market throughout the forecast period.

Contrast Media Market- Market Dynamics

Rise in healthcare spending

The primary driver of the market's expansion is the rise in healthcare spending. The market is anticipated to be impacted by the notable rise in medical expenditures in a number of nations in recent years. For instance, during the projection period, the demand for contrast media in various diagnostic imaging would be driven by the anticipated growth in healthcare facility spending due to the rise in disposable income. For example, healthcare expenditures made up 18.3% of the US GDP in 2022, up from 17.6% in 2019. Additionally, healthcare costs are rising in a number of countries, including Brazil and India. Thus, the adoption of sophisticated medical facilities will be greatly influenced by the rising costs of healthcare. Therefore, the expansion of the contrast media market is anticipated to be driven by countries' increased healthcare spending in order to improve the healthcare infrastructure, satisfy patients' increasing needs, and provide cutting-edge medical treatment.

Contrast Media Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2025-2032)

Based on product segmentation, the iodinated was predicted to show maximum market share in the year 2024

Based on route of administration segmentation, intravenous was the leading segment in 2024

Based on application segmentation, neurological disorders were the leading segment in 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Contrast Media Market- Segmentation Analysis:

The Global Contrast Media Market is segmented on the basis of Product, Modality, Route of Administration, Application, End-use, and Region.

On the basis of product, the market is segregated into Microbubble, Iodinated, Gadolinium-Based, and Barium-Based. In 2024, the market was dominated by the iodinated category, ascribed to the widespread use of CT and X-ray techniques as well as the accessibility of stable, nonionic iodinated substances for better diagnosis. Although barium-based contrast media are sometimes used for oral and rectal delivery, iodinated contrast media are typically given intravenously. CT and X-ray pictures are improved by using contrast media based on iodine. Additionally, they are employed to improve the imaging of the brain, soft tissues, arteries and veins, internal organs, and the gastrointestinal tract. In addition to cancer, iodinated contrasting media can be used for a wide range of indications, such as neurological, gastrointestinal, nephrological, cardiovascular, and musculoskeletal problems.

Based on application, the market is divided into Musculoskeletal Disorders, Cancer, Nephrological Disorders, Cardiovascular Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others. In 2024, the neurological disorders category held a dominant market share. Since MRI contrast media produce superior images of brain structures than CT, their use is encouraged by diagnostic evaluation of the central nervous system for neurological illnesses. Gadolinium-based contrast agents are used to visualize demyelinated, inflammatory, and neoplastic lesions. In one in three MRIs, gadolinium-based contrast agents are employed to improve picture quality. By making blood vessels, inflammation, and tumours more visible, these contrast agents increase the accuracy of the diagnosis. The three most often used macrocyclic gadolinium-based contrast agents in the United States for the diagnosis of neurological diseases are Gadavist, Dotarem, and Prohance. Adults and children two years of age and up may get them intravenously to view abnormally vascularized brain, spine, and related tissue abnormalities.

Contrast Media Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Contrast Media. The increased funding for biomedical research from both government and non-governmental groups is largely responsible for the market's rise. On October 3, 2022, for instance, SNMMI announced a US$100,000 award for nuclear medicine imaging research and development to address lobular mammary neoplasia. This is anticipated to lead to significant expansion. Increased financing in the area enables a lot of research projects, which will lead to more creative ideas for new product releases that require contrast media. Additionally, the growing number of start-ups investing in medical devices is another driver driving the rise of market revenue in this region.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. This is because healthcare infrastructures are getting better, and people are becoming more conscious of the importance of early diagnosis. Furthermore, another reason propelling the growth of this region's market revenue is the rising prevalence of chronic ailments like cancer, neurological disorders, intestinal illnesses, and cardiovascular diseases (CVDs). In India, for example, non-communicable diseases accounted for 63% of all deaths, with cardiovascular diseases accounting for 27% of these deaths, according to the World Health Organization (WHO). Moreover, The number of innovative molecular imaging techniques generated is anticipated to be significantly impacted by the growing number of startups. Throughout the projection period, they are also expected to accelerate market expansion.

Contrast Media Market- Competitive Landscape:

Major companies such as Bayer AG, General Electric Company, Jodas Expoim Pvt. Ltd., Lantheus, and Guerbet, among others, are using strategies including mergers, acquisitions, and partnerships to grow their market share. Additionally, they are launching new products. To increase their customer bases and market shares internationally, major firms are pursuing mergers and acquisitions. Acquisitions provide companies with a better portfolio and a wider geographic reach, which helps them expand their footprint. Disease indication extension is prevalent in this industry since it enables companies to gain the confidence of particular demographic groups. Through approvals for certain indications, businesses can boost the adoption of their products and target specific patient segments. For instance, in April 2023, by launching Pixxoscan (gadobutrol), a macrocyclic, non-ionic gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI), GE HealthCare broadened its range of contrast media. Pixxoscan obtained marketing clearance in Austria after undergoing regulatory evaluation through a decentralized procedure (DCP).

Recent Development

August 2024: Bayer AG said that a Phase III clinical trial for a new gadolinium-based contrast agent with a better relaxivity and safety profile had been completed. This agent may provide improved MRI imaging capabilities for neurological applications.

April 2024: A novel AI-powered contrast media injection device was introduced by GE Healthcare with the goal of enhancing image quality and lowering the risk of contrast-induced nephropathy by optimizing contrast dose and time for customized imaging regimens.

March 2024: The US Food and Drug Administration approved Lantheus Holdings Inc.'s supplemental new drug application (sNDA) for DEFINITY (Perflutren Lipid Microsphere), an ultrasound-enhancing agent intended for use in pediatric patients with poor echocardiograms.

June 2023: The US Food and Drug Administration authorized the iodine-based contrast agents Iopromide-300 and -370 (Ultravist). In addition to mammography and/or ultrasound, the product can be used to visualize known or suspected breast lesions in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTRAST MEDIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bayer AG
  • General Electric Company
  • Jodas Expoim Pvt. Ltd.
  • Lantheus
  • Guerbet
  • SANOCHEMIA Pharmazeutika GmbH
  • TAEJOON PHARM Co. Ltd.
  • Beijing Beilu Pharmaceuticals Company Limited
  • Bracco S.p.A.
  • iMAX Diagnostic Imaging Limited
  • J.B. Chemicals & Pharmaceuticals Limited
  • Nano Therapeutics Pvt Ltd
  • Trivitron Healthcare
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Microbubble
  • Iodinated
  • Gadolinium-Based
  • Barium-Based

GLOBAL CONTRAST MEDIA MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Ultrasound
  • X-ray/Computed Tomography
  • Magnetic Resonance Imaging

GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral Route
  • Intravenous
  • Rectal Route

GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal Disorders
  • Cancer
  • Nephrological Disorders
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Contrast Media Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Contrast Media Market Snippet by Product
    • 2.1.2. Contrast Media Market Snippet by Modality
    • 2.1.3. Contrast Media Market Snippet by Route of Administration
    • 2.1.4. Contrast Media Market Snippet by Application
    • 2.1.5. Contrast Media Market Snippet by End-use
    • 2.1.6. Contrast Media Market Snippet by Country
    • 2.1.7. Contrast Media Market Snippet by Region
  • 2.2. Competitive Insights

3. Contrast Media Key Market Trends

  • 3.1. Contrast Media Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Contrast Media Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Contrast Media Market Opportunities
  • 3.4. Contrast Media Market Future Trends

4. Contrast Media Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Contrast Media Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Contrast Media Market Landscape

  • 6.1. Contrast Media Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Contrast Media Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Microbubble
    • 7.1.3. Iodinated
    • 7.1.4. Gadolinium-Based
    • 7.1.5. Barium-Based

8. Contrast Media Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Ultrasound
    • 8.1.3. X-ray/Computed Tomography
    • 8.1.4. Magnetic Resonance Imaging

9. Contrast Media Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 9.1.2. Oral Route
    • 9.1.3. Intravenous
    • 9.1.4. Rectal Route

10. Contrast Media Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Musculoskeletal Disorders
    • 10.1.3. Cancer
    • 10.1.4. Nephrological Disorders
    • 10.1.5. Cardiovascular Disorders
    • 10.1.6. Gastrointestinal Disorders
    • 10.1.7. Neurological Disorders
    • 10.1.8. Others

11. Contrast Media Market - By End-use

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Others

12. Contrast Media Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Contrast Media Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Contrast Media Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Contrast Media Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Contrast Media Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Contrast Media Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Contrast Media Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Bayer AG
    • 13.2.2. General Electric Company
    • 13.2.3. Jodas Expoim Pvt. Ltd.
    • 13.2.4. Lantheus
    • 13.2.5. Guerbet
    • 13.2.6. SANOCHEMIA Pharmazeutika GmbH
    • 13.2.7. TAEJOON PHARM Co. Ltd.
    • 13.2.8. Beijing Beilu Pharmaceuticals Company Limited
    • 13.2.9. Bracco S.p.A.
    • 13.2.10. iMAX Diagnostic Imaging Limited
    • 13.2.11. J.B. Chemicals & Pharmaceuticals Limited
    • 13.2.12. Nano Therapeutics Pvt Ltd
    • 13.2.13. Trivitron Healthcare
    • 13.2.14. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us